Cargando…
Therapeutic Strategies in HCC: Radiation Modalities
Patients with hepatocellular carcinoma (HCC) comply with an advanced disease and are not eligible for radical therapy. In this distressed scenario new treatment options hold great promise; among them transarterial chemoembolization (TACE) and transarterial metabolic radiotherapy (TAMR) have shown ef...
Autores principales: | Gallicchio, R., Nardelli, A., Mainenti, P., Nappi, A., Capacchione, D., Simeon, V., Sirignano, C., Abbruzzi, F., Barbato, F., Landriscina, M., Storto, G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4987460/ https://www.ncbi.nlm.nih.gov/pubmed/27563661 http://dx.doi.org/10.1155/2016/1295329 |
Ejemplares similares
-
[F-18] FDG-PET/CT parameters as predictors of outcome in inoperable NSCLC patients
por: Nappi, Antonio, et al.
Publicado: (2015) -
Ga-68-Edotreotide Positron Emission Tomography/Computed Tomography Somatostatin Receptors Tumor Volume Predicts Outcome in Patients With Primary Gastroenteropancreatic Neuroendocrine Tumors
por: Gallicchio, Rosj, et al.
Publicado: (2023) -
Strategies for HCC target discovery
por: Molina-Sánchez, Pedro, et al.
Publicado: (2017) -
Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC
por: Wei, Yulong, et al.
Publicado: (2021) -
Pain predicts overall survival in men with metastatic castration-resistant prostate cancer treated with radium-223
por: Roviello, Giandomenico, et al.
Publicado: (2018)